Stock Events

Stock Events

CytomX Therapeutics (6C1.F) Q2 2024 Earnings

6C1.F
May 8Confirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.09
-0.01
0.07
0.16

Details

Expected EPS
-0.0949566513
Actual EPS
0.158151
Surprise EPS
0.25
Surprise Percent
+266.55%

Description

⁨CytomX Therapeutics⁩ (⁦6C1.F⁩) has reported earnings of ⁦0.158151⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts